Michigan SB 3: Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.

Status: referred to Committee on Government Operations (as of 2025-04-24)

State: Michigan · Session: 2025-2026 · Bill: SB 3

Subjects: Health: pharmaceuticals, State agencies (existing): boards and commissions, State agencies (existing): insurance and financial services

Sponsors: Darrin Camilleri, John Cherry, Stephanie Chang

View Michigan SB 3 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.